Cronkhite Canada Syndrome: Significant Response to Infliximab and a Possible Clue to Pathogenesis

Am J Gastroenterol. 2016 May;111(5):746-8. doi: 10.1038/ajg.2016.92.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Adult
  • DNA-Activated Protein Kinase / genetics
  • Endoscopy, Digestive System
  • Female
  • Gastrointestinal Agents / therapeutic use*
  • Humans
  • Infliximab / therapeutic use*
  • Intestinal Polyposis / diagnosis
  • Intestinal Polyposis / drug therapy*
  • Intestinal Polyposis / genetics
  • Intestinal Polyposis / pathology
  • Nuclear Proteins / genetics

Substances

  • Gastrointestinal Agents
  • Nuclear Proteins
  • Infliximab
  • DNA-Activated Protein Kinase
  • PRKDC protein, human